Shield Therapeutics appoints Richard Jones as CFO
This article was originally published in Scrip
Executive Summary
Shield Therapeutics, an independent speciality pharmaceutical company focused on the development of late-stage hospital products, has appointed Richard Jones chief financial officer. Mr Jones has 12 years' experience in corporate finance and broking, having most recently served as director and head of healthcare at Brewin Dolphin Investment Banking, where he advised healthcare companies on financial transactions.